ArticleMolecular biology reports2019
ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance.
Irina Cezara Vacarean-Trandafir et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papertrialcites it